<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on a 25-year-old woman with pronounced <z:hpo ids='HP_0009064'>generalized lipodystrophy</z:hpo> and a progeroid aspect since birth, who also had <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>; fulfilling the Ghent criteria) with mild skeletal features, <z:mp ids='MP_0011575'>dilated aortic bulb</z:mp>, <z:hpo ids='HP_0100775'>dural ectasia</z:hpo>, bilateral subluxation of the lens, and <z:hpo ids='HP_0011003'>severe myopia</z:hpo> in addition to the severe <z:hpo ids='HP_0009064'>generalized lipodystrophy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>She lacked <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo>, <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo>, and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Mutation analysis in the gene encoding fibrillin 1 (FBN1) revealed a novel de novo heterozygous deletion, c.8155_8156del2 in exon 64 </plain></SENT>
<SENT sid="3" pm="."><plain>The severe <z:hpo ids='HP_0009064'>generalized lipodystrophy</z:hpo> in this patient with progeroid features has not previously been described in other patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and FBN1 mutations </plain></SENT>
<SENT sid="4" pm="."><plain>We did not find a mutation in genes known to be associated with congenital <z:hpo ids='HP_0009125'>lipodystrophy</z:hpo> (APGAT2, BSCL2, CAV1, PTRF-CAVIN, PPARG, LMNB2) or with <z:e sem="disease" ids="C0033300" disease_type="Disease or Syndrome" abbrv="">Hutchinson-Gilford progeria</z:e> (ZMPSTE24, LMNA/C) </plain></SENT>
<SENT sid="5" pm="."><plain>Other <z:e sem="disease" ids="C0033300" disease_type="Disease or Syndrome" abbrv="">progeria syndromes</z:e> were considered unlikely because <z:hpo ids='HP_0002216'>premature greying</z:hpo>, <z:hpo ids='HP_0000135'>hypogonadism</z:hpo>, and <z:hpo ids='HP_0100324'>scleroderma</z:hpo>-like <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">skin disease</z:e> were not present </plain></SENT>
<SENT sid="6" pm="."><plain>Our patient shows striking similarity to two patients who have been published in this journal by O'Neill et al </plain></SENT>
<SENT sid="7" pm="."><plain>[O'Neill et al </plain></SENT>
<SENT sid="8" pm="."><plain>(2007); Am J Med Genet Part A 143A:1421-1430] with the diagnosis of <z:e sem="disease" ids="C0406586" disease_type="Disease or Syndrome" abbrv="">neonatal progeroid syndrome</z:e> (NPS) </plain></SENT>
<SENT sid="9" pm="."><plain>This condition also known as <z:e sem="disease" ids="C0406586" disease_type="Disease or Syndrome" abbrv="">Wiedemann-Rautenstrauch syndrome</z:e> is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorder</z:e> characterized by accelerated aging and <z:hpo ids='HP_0009125'>lipodystrophy</z:hpo> from birth, poor postnatal <z:mp ids='MP_0005456'>weight gain</z:mp>, and characteristic facial features </plain></SENT>
<SENT sid="10" pm="."><plain>The course is usually progressive with early <z:mp ids='MP_0010769'>lethality</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>However this entity seems <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>We suggest that our patient and the two similar cases described before represent a new entity, a subgroup of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> with overlapping features to NPS syndrome </plain></SENT>
</text></document>